RGS5 |
RGS5: Regulator of G-protein signaling 5 |
FFAR2 |
FFAR2, GPR43: Free fatty acid receptor 2 |
1.132 |
Evidence |
|
EPHB6 |
EPHB6: Ephrin type-B receptor 6 precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
1.132 |
Evidence |
|
EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
1.132 |
Evidence |
|
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
HRH4 |
HRH4, GPCR105: Histamine H4 receptor |
1.132 |
Evidence |
|
RGS5 |
RGS5: Regulator of G-protein signaling 5 |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
1.132 |
Evidence |
|
PLEK |
PLEK, P47: Pleckstrin |
CHN2 |
CHN2, ARHGAP3, BCH: Beta-chimaerin |
1.132 |
Evidence |
|
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
EDG7 |
EDG7, LPA3: Lysophosphatidic acid receptor Edg-7 |
1.132 |
Evidence |
|
RGS5 |
RGS5: Regulator of G-protein signaling 5 |
EDG8 |
EDG8: Sphingosine 1-phosphate receptor Edg-8 |
1.132 |
Evidence |
|
CHRM3 |
CHRM3: Muscarinic acetylcholine receptor M3 |
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
1.132 |
Evidence |
|
CXCR6 |
CXCR6, BONZO, STRL33, TYMSTR: C-X-C chemokine receptor type 6 |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
1.132 |
Evidence |
|
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
IL2 |
IL2: Interleukin 2 |
1.132 |
Evidence |
|
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
1.132 |
Evidence |
|
CASP1 |
CASP1, IL1BC, IL1BCE: Caspase-1 precursor |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
1.132 |
Evidence |
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINB4 |
SERPINB3, SCCA, SCCA1: Serpin B3 |
1.132 |
Evidence |
|
PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
MAPK15 |
IPI00395861 |
1.132 |
Evidence |
|
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
1.132 |
Evidence |
|
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
F11 |
F11: Coagulation factor XI precursor |
SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
1.132 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
RIN1 |
RIN1: Ras and Rab interactor 1 |
1.132 |
Evidence |
|
GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
1.132 |
Evidence |
|
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
STAT3 |
|
1.132 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
1.132 |
Evidence |
|
AZGP1 |
AZGP1, tcag7.638: Alpha-2-glycoprotein 1, zinc-binding |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
1.132 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|